Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 106,500 KRW
Change Today -1,000.00 / -0.93%
Volume 667.0
As of 10:38 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

ilsung pharmaceuticals co (003120) Snapshot

Open
105,500
Previous Close
107,500
Day High
108,500
Day Low
105,500
52 Week High
06/8/15 - 170,000
52 Week Low
11/18/14 - 84,300
Market Cap
283.3B
Average Volume 10 Days
2.1K
EPS TTM
4,345
Shares Outstanding
2.7M
EX-Date
12/29/14
P/E TM
24.5x
Dividend
500.00
Dividend Yield
0.47%
Current Stock Chart for ILSUNG PHARMACEUTICALS CO (003120)

Related News

No related news articles were found.

ilsung pharmaceuticals co (003120) Related Businessweek News

No Related Businessweek News Found

ilsung pharmaceuticals co (003120) Details

Ilsung Pharmaceuticals Co., Ltd. operates as a pharmaceutical company in South Korea. The company offers antibiotics; diagnostics, such as contrast media; and products for cardiovascular, GI tract, metabolism disorders, ophthalmological disorders, and inhalation anesthetics. Ilsung Pharmaceuticals Co., Ltd. was founded in 1954 and is based in Seoul, South Korea.

Founded in 1954

ilsung pharmaceuticals co (003120) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ilsung pharmaceuticals co (003120) Key Developments

Ilsung Seeks To Sell Stake In Samsung C&T

Ilsung Pharmaceuticals Co. Ltd. (KOSE:A003120) seeks to sell stake in Samsung C&T Corporation (KOSE:A000830). Ilsung plans to sell 3.31 million shares of Samsung C&T for KRW 189.28 billion. The expected transaction settlement date is August 27, 2015.

Ilsung Pharmaceuticals Co. Ltd., Annual General Meeting, Mar 20, 2015

Ilsung Pharmaceuticals Co. Ltd., Annual General Meeting, Mar 20, 2015., at 09:00 Korea Standard Time. Location: Yongsan-gu, Seoul road Wonhyoro 84 9. Agenda: To consider the statement of financial position, income statement and approval of the appropriation of retained earnings; to consider appointment of Audit Committee; and to consider the remuneration limits decided cases.

Ilsung Pharmaceuticals Co. Ltd., Annual General Meeting, Feb 28, 2014

Ilsung Pharmaceuticals Co. Ltd., Annual General Meeting, Feb 28, 2014., at 09:00 Korea Standard Time. Location: 84 way 09 dong. Agenda: To consider the approval of the financial position, income statement; to elect directors; and to consider the determination of directors' remuneration in the ceiling.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
003120:KS 106,500.00 KRW -1,000.00

003120 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 003120.
View Industry Companies
 

Industry Analysis

003120

Industry Average

Valuation 003120 Industry Range
Price/Earnings 25.3x
Price/Sales 2.4x
Price/Book 0.4x
Price/Cash Flow 46.7x
TEV/Sales 3.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ILSUNG PHARMACEUTICALS CO, please visit www.ilsung-ph.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.